Pentax Medical Video Duodenoscope - Product Usage: intended to be used with endoscopic devices an...
FDA Device Recall #Z-1682-2021 — Class II — April 21, 2021
Recall Summary
| Recall Number | Z-1682-2021 |
| Classification | Class II — Moderate risk |
| Date Initiated | April 21, 2021 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Pentax of America Inc |
| Location | Montvale, NJ |
| Product Type | Devices |
| Quantity | 108 units |
Product Description
Pentax Medical Video Duodenoscope - Product Usage: intended to be used with endoscopic devices and other ancillary equipment to provide optical visualization of (via a video monitor), and therapeutic access to, Biliary Tract via the Upper Gastrointestinal Tract, Model Number: ED34-i10T2.
Reason for Recall
IFU updated: The warning section of the IFU for both the OE-A63 distal end cap and ED34-i10T2 duodenoscope has been updated to notify users of the associated risks with the distal end cap (OE-A63) unexpectedly becoming detached during a procedure and updated to notify users of what immediate actions should be taken in case the event occurs. This can result in unforseen events such as mucosal injury, lacerations, or bleeding of the patient. Detachment of the distal end cap (OE-A63) into the oral cavity of the patient may also result in aspiration
Distribution Pattern
US Nationwide distribution in the states of Alabama, California, Louisiana, Maryland, Michigan, Missouri, New Jersey, North Carolina, Pennsylvania, Texas, Washington, D.C.
Lot / Code Information
All units
Other Recalls from Pentax of America Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2329-2025 | Class II | Pentax Medical Video Processor; Model Number: ... | Jul 16, 2025 |
| Z-1236-2025 | Class II | PENTAX Medical Video Colonoscope- Intended to ... | Jan 29, 2025 |
| Z-1238-2025 | Class II | Pentax Medical Video Processor- Intended to be ... | Jan 29, 2025 |
| Z-1237-2025 | Class II | PENTAX Medical Video Upper GI Scope-Intended to... | Jan 29, 2025 |
| Z-2449-2021 | Class II | Gastroscope Family # 1-Gastroscopes without a W... | Jul 14, 2021 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.